$0.2217
-0.01-6.22%
At close: -
$0.2258
0.004101.85%
After Hours: 7:51 PM EDT
Comments
Loading...
X4 Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:XFOR | Benzinga
X4 Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 6
EPS Estimate
$-0.150
Quarterly Revenue Estimate
$2.53M
Annual Revenue
(as of Dec 31)
(as of Dec 31)
$2.56M
Analyze the earnings history of X4 Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| XFOR | X4 Pharmaceuticals | -$0.26 | -$0.15 | — | — | $0.00 | $2.53M | — | — | 05/06/2025 | Get Alert |
| XFOR | X4 Pharmaceuticals | -$0.10 | -$0.16 | -$0.20 | -25.00% | $0.00 | $1.06M | $1.43M | 35.28% | 03/25/2025 | Get Alert |
| XFOR | X4 Pharmaceuticals | -$0.01 | -$0.17 | -$0.18 | -5.88% | $0.00 | — | $560.00K | — | 11/13/2024 | Get Alert |
| XFOR | X4 Pharmaceuticals | -$0.33 | $0.01 | -$0.07 | -800.00% | $0.00 | $280.00K | $563.00K | 101.07% | 08/08/2024 | Get Alert |
| XFOR | X4 Pharmaceuticals | -$0.16 | -$0.16 | -$0.26 | -62.50% | $0.00 | — | $0.00 | — | 05/07/2024 | Get Alert |
| XFOR | X4 Pharmaceuticals | -$0.29 | -$0.15 | -$0.10 | 33.33% | $0.00 | — | $0.00 | — | 03/21/2024 | Get Alert |
| XFOR | X4 Pharmaceuticals | -$0.26 | -$0.15 | -$0.01 | 93.33% | $0.00 | — | $0.00 | — | 11/09/2023 | Get Alert |
| XFOR | X4 Pharmaceuticals | -$0.60 | -$0.16 | -$0.33 | -106.25% | $0.00 | — | $0.00 | — | 08/10/2023 | Get Alert |
| XFOR | X4 Pharmaceuticals | -$0.72 | -$0.22 | -$0.16 | 27.27% | $0.00 | — | $0.00 | — | 05/04/2023 | Get Alert |
| XFOR | X4 Pharmaceuticals | -$0.91 | -$0.24 | -$0.29 | -20.83% | $0.00 | — | $0.00 | — | 03/21/2023 | Get Alert |
| XFOR | X4 Pharmaceuticals | -$0.76 | -$0.30 | -$0.26 | 13.33% | $0.00 | — | $0.00 | — | 11/03/2022 | Get Alert |
| XFOR | X4 Pharmaceuticals | -$0.74 | -$0.64 | -$0.60 | 6.25% | $0.00 | — | $0.00 | — | 08/04/2022 | Get Alert |
| XFOR | X4 Pharmaceuticals | -$1.30 | -$0.61 | -$0.72 | -18.03% | $0.00 | $120.00K | $0.00 | -100.00% | 05/12/2022 | Get Alert |
| XFOR | X4 Pharmaceuticals | -$0.66 | -$0.68 | -$1.24 | -82.35% | $0.00 | — | $0.00 | — | 03/17/2022 | Get Alert |
| XFOR | X4 Pharmaceuticals | -$0.87 | -$0.72 | -$0.76 | -5.56% | $0.00 | — | $0.00 | — | 11/04/2021 | Get Alert |
| XFOR | X4 Pharmaceuticals | -$0.76 | -$0.74 | -$0.74 | 0.00% | $0.00 | — | $0.00 | — | 08/03/2021 | Get Alert |
| XFOR | X4 Pharmaceuticals | -$0.56 | -$0.86 | -$1.30 | -51.16% | $3.00M | — | $0.00 | — | 05/06/2021 | Get Alert |
| XFOR | X4 Pharmaceuticals | — | -$0.90 | -$0.91 | -1.11% | — | — | $0.00 | — | 03/04/2021 | Get Alert |
| XFOR | X4 Pharmaceuticals | -$0.94 | -$0.76 | -$0.87 | -14.47% | $0.00 | — | $0.00 | — | 11/05/2020 | Get Alert |
| XFOR | X4 Pharmaceuticals | -$1.02 | -$0.72 | -$0.76 | -5.56% | $0.00 | — | $0.00 | — | 07/30/2020 | Get Alert |
| XFOR | X4 Pharmaceuticals | -$6.67 | — | -$0.56 | — | $0.00 | — | $3.00M | — | 05/07/2020 | Get Alert |
X4 Pharmaceuticals (XFOR) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-25 | $-0.20 | $-0.16 | -25.0 % |
| Q3 | 2024-11-13 | $-0.18 | $-0.17 | -5.88 % |
| Q2 | 2024-08-08 | $-0.07 | $0.01 | -800.0 % |
| Q1 | 2024-05-07 | $-0.26 | $-0.16 | -62.5 % |
X4 Pharmaceuticals (XFOR) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q4 | 2025-03-25 | $1.43M | $1.06M | 35.3 % |
| Q2 | 2024-08-08 | $563.00K | $280.00K | 101.1 % |
| Q1 | 2022-05-12 | $0 | $120.00K | -100.0 % |
FAQ
When is X4 Pharmaceuticals (NASDAQ:XFOR) reporting earnings?
X4 Pharmaceuticals (XFOR) is scheduled to report earnings on May 6, 2025. The last reported earnings were for reported on March 25, 2025 for Q4.
What were the latest earnings per share (EPS) for X4 Pharmaceuticals (NASDAQ:XFOR)?
The Actual EPS was $-0.20, which missed the estimate of $-0.16.
What were X4 Pharmaceuticals’s (NASDAQ:XFOR) revenues?
The Actual Revenue was $1.4M, which beat the estimate of $1.1M.
Browse earnings estimates, EPS, and revenue on all stocks.